Arterial Hypertension and Renal Allograft Survival
Top Cited Papers
Open Access
- 2 February 2000
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 283 (5) , 633-638
- https://doi.org/10.1001/jama.283.5.633
Abstract
Renal transplantation has emerged as the treatment of choice for many patients with end-stage renal disease.1 However, despite marked improvements in short-term allograft function with administration of newer potent immunosuppressive medications, long-term allograft survival continues to be inadequate, with allograft failure being one of the most important reasons for (re)initiating long-term dialysis treatment in the United States.Keywords
This publication has 9 references indexed in Scilit:
- Association of chronic kidney graft failure with recipient blood pressureKidney International, 1998
- Blood Pressure and End-Stage Renal Disease in MenNew England Journal of Medicine, 1996
- Racial differences in renal allograft survival: The role of systemic hypertensionKidney International, 1995
- The Role of Hypertension as a Damaging Factor for Kidney Grafts Under Cyclosporine TherapyAmerican Journal of Kidney Diseases, 1993
- Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusionKidney International, 1993
- Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research GroupJAMA, 1992
- THE EFFECT OF HIGH-DOSE NIFEDIPINE ON RENAL HEMODYNAMICS OF CYCLOSPORINE-TREATED RENAL ALLOGRAFT RECIPIENTSTransplantation, 1992
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972